Drug Trial Radar · NCT06206421
A Study to Assess Long-term Safety of Fezolinetant Given to Japanese Women Going Through Menopause
Last checked: Nov 20, 2026Latest source record: Apr 8, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
277
Actual
Start
Feb 22, 2024
Primary completion
Mar 19, 2026
Study completion Mar 19, 2026
Sponsor
- Lead sponsor
- Astellas Pharma IncAstellas (ALPMY)
- Sponsor type
- Industry
- First posted
- Jan 16, 2024
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Triple (participant, investigator, outcomes assessor)
- Primary purpose
- Treatment
- FDA-regulated drug
- No
- Who can join
- Female only, from 40 years, up to 65 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
Hot flashes are the most common reason women going through menopause seek medical attention. Hormone replacement therapy, or HRT, is most often prescribed to treat hot flashes. However, HRT can't be used by all women or for as long as may be needed. Researchers want to find other ways to treat hot flashes. Fezolinetant is a medicine to treat hot flashes in women going through menopause. Fezolinetant is an approved medicine in the US. Further studies are needed before it is available in other regions such as Asia. In this study fezolinetant will be used to treat hot flashes in Japanese women going through menopause. This study will confirm the safety of fezolinetant and how well the women tolerate the treatment. Women will either take fezolinetant or a placebo. This is decided by chance alone. The placebo looks like fezolinetant but will not have any medicine in it. The women will take 1 tablet of the study medicine (fezolinetant or the placebo) once a day for up to 52 weeks. During the study, the women will visit their study clinic for a check-up about every 4 weeks for up to 52 weeks (1 year). At each visit they will be asked if they had any medical problems. Other checks will include a medical examination and vital signs (temperature, blood pressure and pulse). At some visits, the women will have an ECG to check their heart rhythm and some blood and urine samples will be taken for laboratory tests. During a couple of visits, women who have a womb (uterus) will also have a test called a transvaginal ultrasound. A probe is gently placed inside the vagina. Sound waves will create a picture of the organs in the pelvis. This will allow the study doctor to look more closely at the uterus and surrounding organs. The last clinic visit will be 3 weeks after the women take their final tablet of the study medicine (fezolinetant or the placebo).
Conditions
- Hot Flashes
Interventions
FezolinetantDrug
oral
PlaceboDrug
oral
Primary outcomes
What the sponsor says the trial is designed to measure.
- Number of participants with Adverse Events (AEs)Time frame: Up to Week 55
Locations
24 sites in 1 country. Site status is shown where the registry gives one.
Daido Clinic
Nagoya, Aichi-ken, Japan
Juno Vesta Clinic hatta
Matsudo-shi, Chiba, Japan
Mori Ladies Clinic
Fukuoka, Fukuoka, Japan
Kotoni Ladies Clinic
Sapporo, Hokkaido, Japan
M's Ladies Clinic
Sapporo, Hokkaido, Japan
NISHIKAWA Women's Health Clinic
Sapporo, Hokkaido, Japan
Motomachi Ladies Clinic
Yokohama, Kanagawa, Japan
Women's Clinic LUNA Yokohama Motomachi
Yokohama, Kanagawa, Japan
Chieko Yukika Lady's Clinic
Sendai, Miyagi, Japan
GyNet Medical Corporation Minamimorimachi Ladies' Clinic
Osaka, Osaka, Japan
Ninomiya Ladies Clinic
Osaka, Osaka, Japan
Rikako Ladies Clinic
Osaka, Osaka, Japan
Tennoji Chihiro Women's Clinic
Osaka, Osaka, Japan
Shimizu Ladies Clinic
Sakai-shi, Osaka, Japan
jMOG Medical Corporation Tanabe Ladies' Clinic
Takatsuki-shi, Osaka, Japan
Marunouchi no Mori Ladies Clinic
Chiyoda-ku, Tokyo, Japan
Ginza Yoshida Medical Clinic
Chuo-ku, Tokyo, Japan
Medical Corporation Asbo Tokyo Asbo Clinic
Chuo-ku, Tokyo, Japan
Medical Corp.SEIKOUKAI New Medical Research System Clinic
Hachioji-shi, Tokyo, Japan
Kichijyoji Ladies Clinic
Musashino-shi, Tokyo, Japan
Shimamura Memorial Hospital
Nerima-ku, Tokyo, Japan
Yukawa Women'S Clinic
Nishi-Tokyo-shi, Tokyo, Japan
Shimodaira Ladies Clinic
Suginami-ku, Tokyo, Japan
Medical Corporation Associa Tamacenter Ladies Clinic
Tama-Shi, Tokyo, Japan
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.